ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ZVRA on Nasdaq
Shares outstanding
56,066,823
Price per share
$8.86
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
38,140,333
Total reported value
$341,727,813
% of total 13F portfolios
0%
Share change
-1,762,405
Value change
-$17,172,722
Number of holders
156
Price from insider filings
$8.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.6% $29,501,437 4,080,420 BlackRock, Inc. 31 Dec 2024
Woodline Partners LP 6.2% $33,058,120 3,476,143 Woodline Partners LP 30 Sep 2025
Nantahala Capital Management, LLC 4.4% -20% $16,920,608 -$4,220,064 2,340,333 -20% Nantahala Capital Management, LLC 31 Dec 2024
Adage Capital Management, L.P. 4% -41% $21,159,750 -$13,551,750 2,225,000 -39% Adage Capital Management, L.P. 30 Sep 2025

As of 31 Dec 2025, 156 institutional investors reported holding 38,140,333 shares of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA). This represents 68% of the company’s total 56,066,823 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8% 4,507,051 +12% 0% $40,383,177
Woodline Partners LP 6.2% 3,450,844 -0.73% 0.12% $30,919,562
VANGUARD GROUP INC 5.9% 3,305,207 +7.2% 0% $29,614,655
FMR LLC 4.3% 2,393,493 +46% 0% $21,445,699
Nantahala Capital Management, LLC 3.2% 1,771,936 -10% 0.95% $15,876,546
STATE STREET CORP 2.6% 1,482,956 +3.9% 0% $13,287,286
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,341,681 +3.2% 0% $12,024,511
MORGAN STANLEY 2.1% 1,157,913 +108% 0% $10,374,901
MILLENNIUM MANAGEMENT LLC 2% 1,134,358 +9.6% 0.01% $10,163,848
Legal & General Group Plc 2% 1,097,988 +4.2% 0% $9,837,973
683 Capital Management, LLC 1.6% 905,000 -7.2% 0.67% $8,108,800
ROYCE & ASSOCIATES LP 1.5% 865,822 +25% 0.08% $7,757,765
D. E. Shaw & Co., Inc. 1.5% 863,746 +19% 0.01% $7,739,164
CITADEL ADVISORS LLC 1.5% 842,854 +339% 0.01% $7,551,972
TUDOR INVESTMENT CORP ET AL 1.2% 692,097 +55% 0.03% $6,201,189
MARSHALL WACE, LLP 1.2% 669,742 -27% 0.01% $6,000,889
Retirement Planning Co of New England, Inc. 1.2% 662,976 +10% 2.4% $5,940,265
GOLDMAN SACHS GROUP INC 1% 588,700 -23% 0% $5,274,752
KINGDON CAPITAL MANAGEMENT, L.L.C. 1% 585,069 -10% 0.8% $5,242,218
Stonepine Capital Management, LLC 1% 569,088 -30% 4.1% $5,099,028
JANE STREET GROUP, LLC 1% 563,906 +163% 0.01% $5,052,598
Caption Management, LLC 0.96% 540,112 +5.9% 0.21% $4,839,404
SCHRODER INVESTMENT MANAGEMENT GROUP 0.9% 506,033 +23% 0% $4,458,151
NORTHERN TRUST CORP 0.75% 418,122 -4.9% 0% $3,746,373
JPMORGAN CHASE & CO 0.74% 412,261 -6.1% 0% $3,693,858

Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 38,140,333 $341,727,813 -$17,172,722 $8.96 156
2025 Q3 39,900,415 $379,438,207 +$36,779,127 $9.51 164
2025 Q2 36,165,830 $318,624,169 +$9,847,978 $8.81 119
2025 Q1 35,351,805 $264,779,873 +$11,437,756 $7.49 109
2024 Q4 33,925,967 $282,929,757 +$43,767,647 $8.34 108
2024 Q3 28,925,387 $200,746,422 +$88,219,086 $6.94 105
2024 Q2 16,043,055 $78,561,424 +$9,453,621 $4.90 92
2024 Q1 13,910,496 $80,679,510 +$7,031,758 $5.80 88
2023 Q4 12,678,435 $83,043,757 +$12,292,891 $6.55 83
2023 Q3 10,800,557 $52,059,801 +$12,731,917 $4.82 76
2023 Q2 8,153,478 $41,582,121 +$9,633,583 $5.10 69
2023 Q1 6,153,233 $33,836,990 +$3,326,482 $5.50 59
2022 Q4 5,912,306 $27,146,724 -$3,423,716 $4.59 66
2022 Q3 6,683,041 $41,695,480 -$3,025,737 $6.24 63
2022 Q2 7,231,996 $32,280,920 -$8,047,771 $4.46 61
2022 Q1 8,999,997 $45,269,137 +$8,091,446 $5.03 72
2021 Q4 7,241,315 $62,973,380 -$7,065,660 $8.71 72
2021 Q3 7,785,907 $72,596,741 -$2,908,464 $9.33 65
2021 Q2 7,669,356 $98,321,566 +$70,526,213 $12.82 66
2021 Q1 2,343,772 $21,986,514 +$21,240,741 $9.20 46
2020 Q4 1,660 $19,000 +$14,000 $11.70 2
2020 Q3 410 $5,000 $12.20 1
2020 Q2 410 $5,000 $12.20 1
2020 Q1 410 $5,000 $12.20 1
2019 Q4 410 $5,000 $12.20 1
2019 Q3 410 $5,000 $12.20 1
2019 Q2 410 $5,000 $12.20 1
2019 Q1 410 $5,000 $12.20 1